21 October 2017
News and Views
Links and Services
A study in the latest Alimentary Pharmacology & Therapeutics evaluates the effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in U.S. veterans.
Real-world effectiveness data are needed to inform hepatitis C virus (HCV) treatment decisions.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors